Association Betweenq MAFLD ( Metabolic Associated Fatty Liver Disease) and Chronic Kidney Disease
NCT06135467 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2023-11-18
Summary
Assess frequency of renal affection in mafld
Conditions
- Mafld in Ckd Patients
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-04-14
- Primary Completion
- 2025-11-14
- Completion
- 2025-11-15
More Related Trials
-
The Impact of Misclassification of Obesity by Body Mass Index on Mortality in Patients With Chronic Kidney Disease
NCT03285074 ·Status: COMPLETED
-
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: the Correlation Analysis and Risk Prediction Model Study
NCT03534908 ·Status: UNKNOWN
-
Body Fat Mass Association With Clinical Metabolic Profiles, Markers of Inflammation and Adipocytokines
NCT02799719 ·Status: COMPLETED
-
Validity of Laboratory Biomarkers in Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) and It's Consequences
NCT06908122 ·Status: NOT_YET_RECRUITING
-
Role Of Serum Adiponectin In The Ealy Detection Of Renal Impairment In Patients With Non Alcoholic Fatty Liver Disease
NCT05556135 ·Status: UNKNOWN
-
Assessment of the Association Between Visceral Obesity and the Progression of Diabetic Nephropathy
NCT06563791 ·Status: NOT_YET_RECRUITING
-
BeijngFH Health Cohort Study
NCT05546086 ·Status: RECRUITING
-
Fatty Liver Disease Collaborative Research in China
NCT02391168 ·Status: UNKNOWN
-
Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD
NCT02285218 ·Status: UNKNOWN
-
Serum Adiponectin as an Early Marker for Renal Impairment in Patients With Non-alcoholic Fatty Liver Disease.
NCT05106049 ·Status: UNKNOWN
-
The Potential Value and Impact of Diagnostic Biomarkers for MAFLD Using Machine Learning Methods
NCT06061640 ·Status: UNKNOWN
-
Genetical Background of Non-alcoholic Fatty Liver Disease (NAFLD) in Diabetes Mellitus and in Chronic Kidney Disease
NCT02947568 ·Status: UNKNOWN
-
A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes
NCT07241195 ·Status: NOT_YET_RECRUITING
-
Adiponectin and Circulating Macrophage Phenotypes in Non-alcoholic Fatty Liver Disease (NAFLD)
NCT01472120 ·Status: UNKNOWN
-
Effect of Fatty Liver Disease on Bone Density
NCT04850547 ·Status: UNKNOWN
-
Screening for NAFLD in Flanders
NCT04647409 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cognitive Assessment and Brain Function Evaluation in Patients With Non-alcoholic Fatty Liver Disease
NCT05563259 ·Status: ENROLLING_BY_INVITATION
-
Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
NCT05421572 ·Status: UNKNOWN
-
Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)
NCT00983463 ·Status: ENROLLING_BY_INVITATION
-
Metabolic Subtypes of Non-Alcoholic Fatty Liver Disease
NCT05560997 ·Status: UNKNOWN
-
Weight Gain After Smoking Cessation and NAFLD
NCT05550688 ·Status: COMPLETED
-
Prevalence of MAFLD Among Nurses and the Role of Intermittent Fasting
NCT05880316 ·Status: UNKNOWN ·Phase: NA
-
Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD)
NCT02363309 ·Status: COMPLETED
-
De Novo Lipogenesis in Severity of NAFLD
NCT03683589 ·Status: COMPLETED
-
Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients
NCT04059029 ·Status: UNKNOWN